As of 2026-10-11, the Relative Valuation of SpringWorks Therapeutics Inc (SWTX) is (93.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.99 USD, the upside of SpringWorks Therapeutics Inc based on Relative Valuation is -298.7%.
The range of the Relative Valuation is (86.64) - (99.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.6x - 29.4x | 27.5x |
| Forward P/E multiples | 25.7x - 30.1x | 27.9x |
| Fair Price | (86.64) - (99.12) | (93.39) |
| Upside | -284.4% - -310.9% | -298.7% |
| Date | P/E |